FDA, Gates Foundation, UnitedHealth Group, Quantigen, and U.S. Cotton Collaborate to Address Testing Supply Needs


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ FDA Gates Foundation UnitedHealth Group Quantigen, and US Cotton Collaborate to Address Testing Supply Needs
This finding that spun synthetic swabs could be used for COVID-19 testing is based on results from a clinical investigation that represents a collaboration between the FDA, UnitedHealth Group, the Gates Foundation, and Quantigen

The U.S. Food and Drug Administration announced a further expansion of COVID-19 testing options through the recognition that spun synthetic swabs – with a design similar to Q-tips – could be used to test patients by collecting a sample from the front of the nose.

As part of this effort, U.S. Cotton, the largest manufacturer of cotton swabs and a subsidiary of Parkdale-Mills, developed a polyester-based Q-tip-type swab that is fully synthetic for compatibility with COVID-19 testing. Harnessing its large-scale U.S.-based manufacturing capabilities, U.S. Cotton plans to produce these new polyester swabs in large quantities to help meet the needs for coronavirus diagnostic testing.

"This action today demonstrates the ingenuity that results from the FDA working in partnership with the private sector. The Trump Administration has been working side-by-side with our industry partners to fight this pandemic, and today is a great example of that work. We appreciate work by UnitedHealth Group, Quantigen, and the Gates Foundation to perform and support the clinical studies necessary for this advancement. We also want to acknowledge U.S. Cotton's efforts to manufacture a new type of swab for COVID-19 testing that can be produced at scale. We appreciate the work of these collaborators to consider how these test supplies could be broadly distributed to meet not only the testing needs of the United States but also global needs around the pandemic. All of these actions by these American organizations will help continue to expand our testing capability," said FDA Commissioner Stephen M. Hahn, M.D.

This finding that spun synthetic swabs could be used for COVID-19 testing is based on results from a clinical investigation that represents a collaboration between the FDA, UnitedHealth Group, the Gates Foundation, and Quantigen. The type of testing at the front of the nose used in this study is notable because it allows self-collection by patients thereby limiting exposure of healthcare providers; it is more comfortable for patients and it can be performed by a swab that is more readily available and manufacturable at scale.

Tags : #FDA #United #Health #Group #The #Gates #Foundation #Quantigen

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

KIMS Hospitals Takes Another Major Step Forward in Cancer Care with Advanced TrueBeam TechnologyNovember 04, 2026
SRM Medical College Hospital and Research Centre Hosts National Conference on Translational Regenerative Biology and Bioengineering – TRBB 2026November 04, 2026
15-Month-Old Russian Baby Avoids Lung Transplant Following Treatment at MGM HealthcareNovember 04, 2026
Why Diabetes Care Must Go Beyond Blood Sugar ControlNovember 04, 2026
Sri Sathya Sai Heart Hospital Successfully Organises Free Heart Camp, Screening for 550 Patients in Dehradun, UttarakhandNovember 04, 2026
Expert Quote | Rising Air Pollution in Delhi | Agilus DiagnosticsNovember 04, 2026
Healthcare AI Safety Officers: India's New Leadership NeedNovember 04, 2026
Next-Generation Medical Imaging: Beyond Traditional ScansNovember 04, 2026
Menopause Care in India: Building Awareness Beyond Reproductive YearsNovember 04, 2026
Endometriosis in India: Why Diagnosis and Care Coordination MatterNovember 04, 2026
Newborn Screening in India: What Families Should Know About Early TestsNovember 03, 2026
Organ Donation in India: How the Transplant Coordination Journey WorksNovember 03, 2026
Digitising CSSD Instrument Tracking Across Hospital Sterilisation CyclesNovember 03, 2026
How Hospitals Can Audit AI Tools Before DeploymentNovember 03, 2026
Microfluidics in Healthcare: Why Tiny Technology Could Have a Huge ImpactNovember 03, 2026
Evaluating CTEPH: V/Q Scans, Right Heart Catheterization, & Pulmonary EndarterectomyNovember 02, 2026
Interleukin Inhibitors vs Traditional Systemics in Resistant PsoriasisNovember 02, 2026
The Role of Community Pharmacies in Healthcare AccessNovember 02, 2026
How Diagnostic Networks Can Support Timely Referral DecisionsNovember 02, 2026
Health Insurance for India's Gig Economy: What Must ChangeNovember 02, 2026